Thermo Fisher Launches CorEvitas Obesity Registry

Advancing Real-World Insights for Obesity Care

Thermo Fisher Scientific has introduced the PPD™ CorEvitas™ Obesity Registry, a new real-world data initiative designed to evaluate long-term treatment outcomes for obesity therapies. The registry collects clinical and patient-reported information to better understand how obesity treatments perform in everyday healthcare settings.

Real-World Evidence in Clinical Practice

The registry is built to capture ongoing data from healthcare providers and patients over time. This includes treatment patterns, safety outcomes, adherence levels, and patient experiences. The goal is to generate practical insights that complement traditional clinical trials and support evidence-based care.

Comprehensive Data Collection Model

By combining physician-reported clinical data with patient feedback, the CorEvitas Obesity Registry provides a broader view of treatment effectiveness. This approach helps identify real-world trends in therapy use, response, and long-term outcomes.

Part of the CorEvitas Registry Network

The Obesity Registry becomes the 15th independent registry under the CorEvitas Clinical Registries platform. This established system already supports large-scale data collection across multiple disease areas, helping researchers and healthcare teams make informed decisions.

Key Features

• Prospective real-world data collection

• Physician and patient-reported outcomes

• Long-term treatment tracking

• Focus on safety, effectiveness, and adherence

• Regulatory-grade clinical data standards

Applications

• Obesity treatment evaluation

• Clinical research and outcomes studies

• Healthcare decision support

• Therapy performance analysis

• Patient care optimization

Supporting Better Obesity Care

Through the CorEvitas Obesity Registry, Thermo Fisher Scientific strengthens its commitment to real-world science. By delivering reliable, long-term treatment insights, the registry helps improve clinical understanding, guide future research, and support better care for people living with obesity.